Published in Int J Oncol on August 23, 2017
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev (2010) 6.05
The Hippo pathway and human cancer. Nat Rev Cancer (2013) 5.17
Expression of Yes-associated protein in common solid tumors. Hum Pathol (2008) 4.61
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol (2009) 3.26
The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer (2015) 2.74
YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell (2014) 2.70
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol (2013) 2.58
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell (2015) 2.31
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev (2010) 2.00
The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep (2014) 1.73
A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell (2014) 1.68
Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta (2013) 1.31
Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol (2010) 1.09
Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol (2006) 1.09
Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther (2013) 1.09
Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer (2014) 1.08
Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett (2008) 1.08
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med (2012) 1.01
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors. Hepatology (2015) 0.96
Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells. Mol Cancer Ther (2014) 0.95
MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. Cell Death Dis (2015) 0.94
Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. Stem Cell Res Ther (2014) 0.92
Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway. Mol Cancer Res (2015) 0.87
Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis. Int J Immunopathol Pharmacol (2012) 0.82
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Cell Death Differ (2016) 0.82
Identifying therapeutic targets in gastric cancer: the current status and future direction. Acta Biochim Biophys Sin (Shanghai) (2015) 0.81
HucMSC Exosome-Delivered 14-3-3ζ Orchestrates Self-Control of the Wnt Response via Modulation of YAP During Cutaneous Regeneration. Stem Cells (2016) 0.81
Hypoxia-conditioned media allows species-specific attraction of bone marrow stromal cells without need for recombinant proteins. BMC Vet Res (2014) 0.81
Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget (2015) 0.81
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. Oncogene (2015) 0.81
Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1. Oncol Lett (2015) 0.80
CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma. Am J Pathol (2016) 0.79
Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer. J Exp Clin Cancer Res (2016) 0.79
Clinical outcomes of gastrointestinal stromal tumor in southern Thailand. World J Gastrointest Oncol (2012) 0.79
RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer. Oncogene (2015) 0.79
Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. J Exp Clin Cancer Res (2015) 0.79
GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer. Oncogene (2016) 0.79
Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling. Oncotarget (2016) 0.79
MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway. Am J Cancer Res (2016) 0.78
Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget (2016) 0.78
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo. Oncotarget (2016) 0.78
miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation. Oncotarget (2016) 0.78
Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression. Tumour Biol (2016) 0.78
MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU. Cancer Lett (2016) 0.78
Gastrin promotes the metastasis of gastric carcinoma through the β-catenin/TCF-4 pathway. Oncol Rep (2016) 0.78
Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression. J Cancer Res Clin Oncol (2014) 0.77
PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness. Sci Rep (2016) 0.76
Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells. BMC Cancer (2016) 0.75
Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway. Mol Med Rep (2016) 0.76
Extracellular regulated protein kinases 1/2 phosphorylation is required for hepatic differentiation of human umbilical cord-derived mesenchymal stem cells. Exp Biol Med (Maywood) (2015) 0.75
Neutrophils in cancer development and progression: Roles, mechanisms, and implications (Review). Int J Oncol (2016) 0.75
[Corrigendum] Neutrophils in cancer development and progression: Roles, mechanisms, and implications (Review). Int J Oncol (2016) 0.75
Curcumin reverses tobacco smoke‑induced epithelial‑mesenchymal transition by suppressing the MAPK pathway in the lungs of mice. Mol Med Rep (2017) 0.75
Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition. Oncol Rep (2017) 0.75